Back to STIFEL FINANCIAL CORP STIFEL FINANCIAL CORP

BDTXBDTX
12 quarters

Position history for STIFEL FINANCIAL CORPSTIFEL FINANCIAL CORP's holdings in BLACK DIAMOND THERAPEUTICS I

STIFEL FINANCIAL CORP holds 281,245 shares of BDTX (BLACK DIAMOND THERAPEUTICS I), worth $520,304 as of 2026-Q2. The position was increased (+0.9% shares). BDTX represents 0.0% of STIFEL FINANCIAL CORP's portfolio.

Current Value

$520,304

Current Shares

281,245

Total Value Change

+$462,617

Total Shares Change

+261,145

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
281,245
+0.9%
$520,3040.0%$1.85
24
2026-Q1
Increased
278,645
+1.3%
$593,5150.0%$2.30
25
2025-Q4
Increased
274,995
+23.7%
$668,2400.0%$2.49
30
2025-Q3
Increased
222,245
+1.1%
$842,3100.0%$3.73
25
2025-Q2
Increased
219,945
+6.3%
$545,4640.0%$2.35
26
2025-Q1
Increased
206,900
+24.6%
$320,6950.0%$1.61
29
2024-Q4
Increased
166,000
+10.4%
$355,2400.0%$2.15
26
2024-Q3
Increased
150,324
+1.9%
$653,9090.0%$4.23
25
2024-Q2
Decreased
147,500
-0.5%
$687,3500.0%$4.66
0
2024-Q1
Increased
148,300
+32.8%
$751,8810.0%$5.07
32
2023-Q4
Increased
111,700
+455.7%
$313,8770.0%$2.81
38
2023-Q3
New
20,100
-
$57,6870.0%$2.87
29

Other major holders of BDTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used